MedTrace Logo

Allofit® IT Ceramic Bearing System in Total Hip Arthroplasty

NCT03672916 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 185

Last updated 2025-02-12

Study results available
· View outcomes & findings →

Summary

This is a multi-center, prospective, non-controlled post market surveillance study. The objectives of this study are to obtain survival and outcome data on the Allofit IT Shell in combination with the BIOLOX® delta Taper Liner when used in primary total hip arthroplasty.

Conditions

  • Avascular Necrosis of Hip
  • Osteoarthritis, Hip
  • Inflammatory Arthritis
  • Post-Traumatic Osteoarthritis of Hip

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Hassan Achakri · Zimmer Biomet

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2023-04-30
Completion
2023-04-30

Countries

  • Germany
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03672916 on ClinicalTrials.gov